IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Northpond Ventures, LLC

Q3 2024 Holdings

Filed 2024-11-14 | 3 holdings | $43.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kyverna Therapeutics Inc(KYTX)COM501976104$15.9M3,255,42636.5%
Vigil Neuroscience Inc(VIGL)COM92673K108$14.3M4,214,49832.8%
Candel Therapeutics Inc(CADL)COM137404109$13.4M1,935,21530.7%